IXHL Cheat Sheet

IXHL Layered Game Plan: Combining Multiple Plays

Current Context (March 10, 2026, mid-afternoon market): ~$5.00–$5.29 (up 18–25% intraday; high $5.45; volume ~785K+). Post-1:30 reverse split momentum surge blending short-term breakout, potential pullback setup, and speculative upside. No fresh major news; treat as technical/volume-driven until catalyst emerges.

DISCLAIMER – EDUCATIONAL / LOW LIABILITY ONLY:
This is NOT financial advice, trade recommendation, or solicitation. Purely speculative framework for experienced traders familiar with high-vol micro-cap biotechs, stops, sizing, and binary risks (dilution history, no revenue, trial outcomes). Markets irrational; extreme swings possible (±50%+). DYOR, verify live data (Yahoo Finance, TradingView), trade only risk capital you can lose entirely. No guarantees—use at your own risk.

Overall Framework: Layered Multi-Play Approach

Combine these plays to capture momentum now while preparing for the likely pullback (common after spikes in low-float biotechs). Prioritize risk control.

1. Primary: Short-Term Momentum / Breakout Continuation — Ride the live surge (highest near-term edge).
2. Secondary: Conservative Pullback / Re-Entry — Best R/R; reload lower if/when it retraces 10–30% (very probable).
3. Tertiary: Stretch / Catalyst Spec — Small lotto for big upside if news hits (asymmetric but low prob).

1. Primary Play: Short-Term Momentum / Breakout Continuation

• Rationale: Today's volume/price action confirms breakout from recent range. Close strong above $5.00–$5.20 (ideally near $5.45 high) sustains momentum.
• Entry: Aggressive at current (~$5.00–$5.30) or minor dip to $4.80–$5.00 intraday/tomorrow.
• Exits / Targets:
  • Quick scalp: $5.45–$5.50 (+5–10%; lock partials, trail rest).
  • Extension: $5.57–$6.00 (pivot/psych; +7–15%).
• Stop: Tight below today's low (~$4.20–$4.50) or entry -5–8%.
• Position Size: 40–60% of total allocation (momentum live).
• Probability Tilt: Higher short-term (~50–70% partial hit) if volume holds; fade risk on overbought signals (e.g., RSI).

2. Secondary Play: Conservative Pullback / Re-Entry

• Rationale: Spikes like today's often see 10–30% retraces to test support (shakes weak hands, confirms buyers). High likelihood before bigger leg up.
• Entry: Scale in on weakness to $4.00–$4.50 (near prior close/support zone; volume bounce confirmation ideal).
• Exits / Targets: $6.00–$7.00 (prior highs + MA resistance; +20–35% from lower entry / +15–35% from baseline).
• Stop: Below $3.80–$3.90 (key pivot/support break = invalidate & exit).
• Position Size: 30–50% of total (add on confirmed hold).
• Probability Tilt: Moderate-high for dip (~50–60%), then rebound (~40–50% to targets).

3. Tertiary Play: Stretch / Catalyst Spec (Optional Kicker)

• Rationale: Biotech asymmetry—if momentum holds + any pipeline news (e.g., IHL-42X sleep apnea updates, partnerships), explosive run possible.
• Entry: From pullback zone ($4.00–$5.00) or small add on strength.
• Exits / Targets: $8.00–$10.00+ (+50–100%+).
• Stop: Same as secondary or looser if news-driven.
• Position Size: Small (10–20%) — lotto-style.
• Probability Tilt: Low (~15–25%) without catalyst, but high reward if triggered.

Execution & Risk Rules (Trader Essentials)

• Total Exposure: Small (1–3% portfolio max) — extreme vol (beta high).
• Scaling: Partial exits at lower targets (e.g., sell 1/3 at $5.50, 1/3 at $6, trail rest). Scale in on pullback.
• Stops: Hard/mental or auto; trail on winners (breakeven after +10–15%).
• Key Triggers / Watch:
  • Bullish: Close >$5.45 + volume >500K; hold $5.00 support.
  • Bearish: Failure at $4.80–$5.00; break <$4.00 = exit longs fast.
• Timeframe: Mostly short (days–1–2 weeks); extend only on catalyst.
• Monitor: Volume (continuation key), RSI (overbought fade risk), news (GlobeNewswire/Yahoo for Incannex releases).

Ride momentum aggressively now, but defend capital—prep to reload lower. Pure technical/volume play until proven otherwise. Verify live charts/quotes always.